A Concise Review Based on Analytical Method Development and Validation of Apremilast in Bulk and Marketed Dosage Form

Apremilast is used for treatment of psoriasis and psoriatic arthritis. It may also be beneficial for other inflammatory diseases relevant to the immune system. The drug functions as a selective enzyme phosphodiesterase 4 (PDE4) inhibitor and avoids the spontaneous development of TNF-alpha from human synovial rheumatoid cells. The present review assesses the different approaches for evaluation of apremilast in bulk material as well as different formulations. A concise review consists of compile and discuss about over 30 methods for analysing apremilast in the biological matrices, the samples of bulk and in different dosage formulations including HPLC, HPTLC, UPLC, LC-MS and UV-spectrophotometry. A concise review represents the compilation and discussion of about more than 30 analytical methods which includes HPLC, HPTLC, UPLC, LC-MS and UV-Spectrophotometry methods implemented for investigation of apremilast in biological matrices, bulk samples and in different dosage formulations. This detailed review will be of great help to the researcher who is working on apremilast. Keywords: Apremilast; Analytical Profile; HPLC; HPTLC; Bioanalytical; Stability indicating